BCL2 and neoplasm: Inhibition of apoptosis through the overexpression of Bcl-2 promotes oncogenesis as demonstrated in some follicular B-lymphomas [15] while, on the other hand, the loss of Bax function has been associated with tumor progression and a bad prognosis in colon and gastric tumors having a microsatellite mutator phenotype [16].